Effect of Atherosclerotic Regression on Total Luminal Size of Coronary Arteries as Determined by Intravascular Ultrasound

American Journal of Cardiology

Volumn 98, Issue 1, 2006, Pages 23-27

  Tardif, Jean Claude ^a   Grégoire, Jean ^a   L'Allier, Philippe L ^a   Ibrahim, Reda ^a   Lavoie, Marc André ^a   LeMay, Michel ^b   Cohen, Eric ^c   Levesque, Sylvie ^a   Keller, Pierre Frédéric ^a   Heinonen, Therese ^a   Guertin, Marie Claude ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTERY DIAMETER; ARTICLE; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACETATES; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SULFONIC ACIDS; TOTAL LUNG CAPACITY; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 33745168604     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.01.052     Document Type: Article

References (25)

1. Sever P.S., Dahlof B., Poulter N.R., Wedel H., Beevers G., Caulfield M., Collins R., Kjeldsen S.E., Kristinsson A., McInnes G.T., et al., ASCOT Investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA). a multicentre randomised controlled trial. Lancet 361 (2003) 1149-1158
2. Shepherd J., Cobbe S.M., Ford I., Isles C.G., Lorimer A.R., MacFarlane P.W., McKillop J.H., Parckard J., and West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333 (1995) 1301-1307
3. Downs J.R., Clearfield M., Weis S., Whitney E., Shapiro D.R., Beere P.A., Langendorfer A., Stein E.A., Kruyer W., and Gotto Jr. A.M. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279 (1998) 1615-1622
4. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals. a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
5. Brown G., Albers J.J., Fisher L.D., Schaefer S.M., Lin J.T., Kaplan C., Zhao X.Q., Bisson B.D., Fitzpatrick V.F., and Dodge H.T. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 323 (1990) 1289-1298
6. Tardif J.C. The future of intravascular ultrasound in the detection and management of coronary artery disease. Can J Cardiol 16 suppl D (2000) 12D-15D
7. Jensen L.O., Thayssen P., Pedersen K.E., Stender S., and Haghfelt T. Regression of coronary atherosclerosis by simvastatin. Circulation 110 (2004) 265-270
8. Nissen S.E., Tsunoda T., Tuzcu E.M., Schoenhagen P., Cooper C.J., Yasin M., Eaton G.M., Lauer M.A., Sheldon W.S., Grines C.L., et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes. a randomized controlled trial. JAMA 290 (2003) 2292-2300
9. Tardif J.C., Gregoire J., Schwartz L., Title L., Laramee L., Reeves F., Lesperance J., Bourassa M.G., L'Allier P.L., Glass M., et al., Canadian Antioxidant Restenosis Trial (CART-1) Investigators. Effects of AGI-1067 and probucol after percutaneous coronary interventions. Circulation 107 (2003) 552-558
10. Tardif J.C., Gregoire J., L'Allier P.L., Anderson T.J., Bertrand O., Reeves F., Title L.M., Alfonso F., Schampaert E., Hassan A., et al., Avasimibe and Progression of Lesions on UltraSound (A-PLUS) Investigators. Avasimibe and Progression of Lesions on UltraSound (A-PLUS) Investigators. Effects of the acyl coenzyme A: cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation 110 (2004) 3372-3377
11. Tardif J.C., Bertrand O.F., Mongrain R., Lesperance J., Gregoire J., Paiement P., and Bonan R. Reliability of mechanical and phased-array designs for serial intravascular ultrasound examinations-animal and clinical studies in stented and non-stented coronary arteries. Int J Card Imaging 16 (2000) 365-375
12. Berenson G.S., Wattigney W.A., Tracy R.E., Newman III W.P., Srinivasan S.R., Webber L.S., Dalferes Jr. E.R., and Strong J.P. Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (the Bogalusa Heart Study). Am J Cardiol 70 (1992) 851-858
13. Tuzcu E.M., Kapadia S.R., Tutar E., Ziada K.M., Hobbs R.E., McCarthy P.M., Young J.B., and Nissen S.E. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults. evidence from intravascular ultrasound. Circulation 103 (2001) 2705-2710
14. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
15. Glagov S., Weisenberg E., Zarins C.K., Stankunavicius R., and Kolettis G.J. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316 (1987) 1371-1375
16. Guedes A., and Tardif J.C. Intravascular ultrasound assessment of atherosclerosis. Curr Atheroscler Rep 6 (2004) 219-224
17. Nissen S.E., Tuzcu E.M., Schoenhagen P., Brown B.G., Ganz P., Vogel R.A., Crowe T., Howard G., Cooper C.J., Brodie B., et al., REVERSAL Investigators. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis. a randomized controlled trial. JAMA 291 (2004) 1071-1080
18. Tardif J.C. Clinical results with AGI-1067. a novel antioxidant vascular protectant. Am J Cardiol 91 suppl (2003) 41A-49A
19. Smilde T.J., van Wissen S., Wollersheim H., Trip M.D., Kastelein J.J., and Stalenhoef A.F. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP). a prospective, randomised, double-blind trial. Lancet 357 (2001) 577-581
20. Taylor A.J., Kent S.M., Flaherty P.J., Coyle L.C., Markwood T.T., and Vernalis M.N. ARBITER: Arterial biology for the investigation of the treatment effects of reducing cholesterol. A randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation 106 (2002) 2055-2060
21. Corti R., Fayad Z.A., Fuster V., Worthley S.G., Helft G., Chesebro J., Mercuri M., and Badimon J.J. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions. A longitudinal study by high-resolution, non-invasive magnetic resonance imaging. Circulation 104 (2001) 249-252
22. Schartl M., Bocksch W., Fateh-Moghadam S., and German Atorvastatin Intravascular Ultrasound Study Group. Effects of lipid-lowering therapy on coronary artery remodeling. Coron Artery Dis 15 (2004) 45-51
23. von Birgelen C., Hartmann M., Mintz G.S., Böse D., Eggebrecht H., Gössl M., Neumann T., Baumgart D., Wieneke H., Schmermund A., et al. Spectrum of remodeling behavior observed with serial long-term (≥12 months) follow-up intravascular ultrasound studies in left main coronary arteries. Am J Cardiol 93 (2004) 1107-1113
24. Tardif J.C., and Lee H.S. Applications of intravascular ultrasound in cardiology. In: Reiber J.H.C., and van der Wall E.E. (Eds). What's New in Cardiovascular Imaging? (1998), Kluwer Academic Publishers, Dordrecht 133-148
25. Zarins C.K., Giddens D.P., Bharadvaj B.K., Sottiurai V.S., Mabon R.F., and Glagov S. Carotid bifurcation atherosclerosis-quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ Res 53 (1983) 502-514